The emergence and implications of SARS-CoV-2 omicron subvariant BA.2.86 on global health
Description
The SARS-CoV-2 subvariant BA.2.86 "Pirola", first identified in Denmark in August 2023, has manifested with a significantly mutated spike protein profile, suggesting a heightened ability to evade vaccine- and infection-induced antibodies. This